Additionally, OPN upregulates angiogenesis via activation of PI3K/Akt and ERK1/2 pathways in breast cancer, whereas it promotes tumor progression via PI3K/Akt/Twist signaling axis in HCC [37]. This evidence concerns the gene SPP1 and breast carcinoma.